iCAD INC Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 9 rows, 9 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-12-29: Reporting owner Subramaniam Somu; Form 4; Security Director Stock (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-12-29: Reporting owner RAPPAPORT STEVEN N; Form 4; Security Director Stock (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-12-29: Reporting owner Goodman Robert L; Form 4; Security Director Stock (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-12-29: Reporting owner Brem Rachel; Form 4; Security Director Stock (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-12-29 | Subramaniam Somu Director | 4 | Director Stock (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,769 5,769 owned after | $3.44 exercise price | 2018-01-03 | |
| 2017-12-29 | RAPPAPORT STEVEN N Director | 4 | Director Stock (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,846 8,846 owned after | $3.44 exercise price | 2018-01-03 | |
| 2017-12-29 | Goodman Robert L Director | 4 | Director Stock (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,384 5,384 owned after | $3.44 exercise price | 2018-01-03 | |
| 2017-12-29 | Brem Rachel Director | 4 | Director Stock (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,538 6,538 owned after | $3.44 exercise price | 2018-01-03 | |
| 2017-12-29 | HOWARD DR LAWRENCE Director | 4 | Director Stock (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,769 10,769 owned after | $3.44 exercise price | 2018-01-03 | |
| 2017-12-29 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,846 8,846 owned after | $3.44 exercise price | 2018-01-03 | |
| 2017-12-29 | Ecock Anthony F Director | 4 | Director Stock (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,692 7,692 owned after | $3.44 exercise price | 2018-01-03 | |
| 2017-10-20 | Ecock Anthony F Director | 4 | Director Stock (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $2.00 exercise price | 2017-10-24 | |
| 2014-02-18 holding as of filing | Goodman Robert L Director | 3 | No securities are beneficially owned Non-derivative · Direct | Holding | 0 owned after | no price filed | 2014-02-18 |